Clinical Trial Update: Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET Imaging [NA]

View source ↗

Summary

A completed University of Zurich clinical trial examined serotonin neurotransmission in MDMA users using a dexfenfluramine challenge with PET imaging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amphetamine Use Disorder
• Amphetamine-related Disorders

Drugs mentioned

• Dexfenfluramine (dexfenfluramine)

Snippet

Sponsor: University of Zurich | Conditions: Amphetamine-Related Disorders, Amphetamine Abuse | NA | Status: COMPLETED